Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Â
Cannabis presentation apa 8 7-19
1. Current Issues in Police &
Public Safety Psychology:
2019
8-7-2019
State Legalization of Marijuana:
Implications for screening
police & public safety personnel
Ashwani K. Garg, MD
Family Medicine
Lifestyle & Integrative Medicine
2. Disclosures
2
I am in no way representing the views of my employer.
All views are my own.
I have no actual or potential conflict of interest
in relation to this program/presentation.
I will be discussing “off-label” uses of medical cannabis.
Cannabis is a schedule I substances as classified by the DEA
which means illegal/no medicinal use.
Cannabis is regulated individually state-by-state, and
while it is allowed by Illinois’ government, the
federal government has chosen not to sue the state or
to prosecute its sale and use.
3. T
H
C
Agenda
3
1. Pharmacology of Cannabis
2. History/Regulation
3. Illinois Experience
4. Workplace issues
risks/benefits and testing
5. Case Study/discussion
C
B
D
4. “Poison is in everything, and no thing is without poison.
The dosage makes it either a poison or a remedy.”
-’Paracelsus’ (1493-1541), German-Swiss physician and alchemist
PHARMAKON (GREEK) = REMEDY OR
POISON
PHARMAKOS = RITUAL HUMAN SACRIFICE
5. Pharmacology of cannabis
• 421 components, 60 pharmacologically active cannabinoids
• THC and CBD are most well understood
• Highly lipophilic
• Dependence, tolerance, addiction
• CB1: brain - antiemetic, analgesia, neuromodulatory
altered mood, memory, judgement, altered perception
• CB2: immune, hematopoietic, spleen, anti-inflammatory; peripheral
• Presynaptic: modulate neurotransmitter release
6.
7. CB1 and CB2 are in a balance, THC/CBD
balance each other
8. Terpenes are additional compounds
found in cannabis
• Terpenes are aromatic oils that enhance
cannabis with aromas and flavors; found in
many other plants
• These terpenes make each strain of
cannabis truly unique and interact with
CBD and THC to give specific health
effects
• Terpenes are notably absent in synthetic
cannabinoid products
11. WE HAVE OUR OWN
ENDOCANNABINOID SYSTEM!
• Anandamide “bliss molecule” found in various tissues of body
• Dark chocolate found to contain anandamide AND compounds that slow
breakdown
• Lifestyle Medicine is known to help all aspects of ECS
• Feet – exercise increases anandamide and sensitivity of receptors
• Fingers – avoidance of alcohol/tobacco/drugs
• Forks (plant-based foods, green tea reduce breakdown of cannabinoids by inhibiting FAAH)
• Sleep (7 hours / night helps brain homeostasis, memory, mood)
• Stress (mindfulness is a way to manage stress)
• Love (physical/emotional affection, massage, kindness, yoga increase oxytocin)
(based on Dr. David Katz, Yale, “We Can Be Disease Proof” in Huff Po)
13. HISTORY OF MARIJUANA
• Cannabis use goes back 1000’s of years – India, China, Greece
• Sir William Osler 1915 advocated for its use in migraine in textbook
• Listed in the US dispensatory 1845
• Recreational use introduced by Mexican immigrants (1910)
• “Reefer Madness” – minorities and lower income communities
• AMA opposed Marihuana Tax Act 1937 (which added $1 tax and discouraged
its use)
• 1941 – taken off USP and national formulary
• 1944 – NY academy of Medicine report – use of marijuana does not induce
violence, insanity, sex crimes, addiction, drug use
• 1969 – Marihuana Tax Act declared unconstitutional against 5th amendment
• 1970 – Schedule I, no further research, illicit drug in same category as Heroin.
• 1988 – Drug-Free Workplace Act: ALL federal grantees drug free, some
contractors
14. 14
Credit: ACLU Jun 2013:
The War on Marijuana
in Black and White
Fox:
Family Guy
Seth MacFarlane, David Zuckerman
15.
16. MEDICINAL CANNABIS
VS
STREET CANNABIS
• There is a big difference between street cannabis and medicinal cannabis
• “Street cannabis” has high levels of THC – within the last 20 years it has
increased from 34mg / joint to 84mg / joint. For comparative reasons,
medicinal use starts with 5-10 mg/day.
• Often street cannabis is intermingled with other illicit substances such as
fentanyl
• “Gateway drug”? Or Gateway DEALER?
• Chicago gangs: 100,000 gang members in 59 gangs (ABC News)
17. State laws on cannabis and CBD
MAP COURTESY | LAWRENCE PASTERNACK, Ph.D., OSU
17
19. Most common certified conditions
1. Cancer
2. HIV/AIDS
3. Amyotrophic lateral sclerosis
4. Multiple sclerosis
Illinois Department of Public Health Annual Progress Report to the General
Assembly: Compassionate Use of Medical Cannabis Pilot Program Act, July
1,2014-June 30, 2015.
20.
21. Medical cannabis use is associated
with decreased pharmaceutical use
boehnke, kevin ET AL
22. PHYSICIAN DILEMMA
• We have no training in the pharmacology of CB1/CB2, THC/CBD
• We are expected to help patients with this – many questions regarding
dosage, forms, types
• Legal state-by-state, but federally illegal. Jeff Sessions has threatened to shut
the whole program down. Banking and insurance restrictions
• No FDA regulation or control such as tobacco and other medications
• State of IL – 41 medical conditions listed
• Physician need only certify medical condition, NOT recommend/endorse use
of cannabis.
• Ideally, patient’s own PCP should fill the form because they have a BONA
FIDE relationship
23. Illinois experience in medical cannabis
Illinois banned recreational cannabis in 1931
1978 Cannabis Control Act: possession of even small amount would result in a
misdemeanor jail sentence up to 30 days
MCPP = medical cannabis pilot program (2013) – 65,000 applications approved
OAPP = opioid alternatives pilot program (2019) – as of now, roughly 6000 certified
Total retail sales since 11-2015: $323,125,506
*** African Americans in IL are 7-8 times more likely than whites to be arrested
than whites despite similar use ***
24.
25.
26. • Cannabis is the most frequently used illegal substance in the world
• Roughly 50% lifetime use in the USA
• Cannabis Use Disorder with heavy chronic use
• Amotivational syndrome: loss of drive and ability to work
• Depersonalization: feeling detached from mental processes and body
• Risk factor for psychosis (1/4 of schizophrenic patients had CUD or cannabis
use d/o)
• Depression/suicidal ideation, anxiety, bipolar depression
• Cognitive deficits, impaired neuropsychologic functioning
• Medical effects including respiratory, cancer, heart, and more
Long-term Effects of Cannabis Use
Understanding that the research is in abusers, not medicinal users.
26
Karila L et. al (France)
Acute and Long-Term Effects of Cannabis Use: A Review
Current Pharmaceutical Design, 2014, 20, 4112-4118
27. • In 2013, an excavator operator turned himself in to face manslaughter in an accident
that caused a building collapse in Philadelphia and killed 6 people
• Sean Benschop, 42, of Philadelphia, had marijuana found in his system
• He ALSO admitted to taking codeine and other Rx drugs, had a soft cast up to his
elbow, and had a previous record of 10 arrests for drug charges, theft, firearms,
and assault.
• 20 people were caught in the fallen debris; 14 were seriously injured with the
accident
Cannabis in the Workplace
Anecdote
27
https://abcnews.go.com/US/excavator-operator-surrenders-
philadelphia-building-collapse/story?id=19356293
28. • The intended and unintended physiologic effects of marijuana on neurocognitive
performance range from several hours to beyond 28 days of subsequent abstinence.
• Blood levels, while useful for MRO reporting, are not indicative of impairment (usually
legally 5 ng/ml)
• Neuropsychologic testing can be useful, and it is no guarantee the worker will improve
by the next day
• MRO’s are inconsistent in enforcement; it may be reasonable to do a medical
investigation when a test is positive and to assess for impairment and suitability for work
• In Illinois, recreational cannabis will be legalized in 2020. MRO’s will have to decide how
to assess positive screens and impairment. Positive screens can remain positive for 1-5
days after use, and with heavy use, up to 1 month afterwards.
Medicinal Cannabis in the Workplace
28
Medical Marijuana in the Workplace: Challenges and Management Options for Occupational Physicians
Goldsmith, RS et al:
JOEM Volume 57, Number 5, May 2015 pp. 518-525
29. • Urine (5-30 days after use)
• Blood (5-30 days after use)
• Breathalyzer – Hound Labs (near 0 2-3 hours after)
Marijuana Testing
29
30. • Middle aged man with inflammatory bowel disease, severe chronic diarrhea, abdominal
pain, joint pain
• Previously using Norco, Percocet, and at one point, Fentanyl and Oxycontin
• Now well controlled on medicinal cannabis together with pharmaceuticals
• Approached his employer’s HR which is Fortune 500 company
• Asked the question:
• Which would you rather have, an employee on a prescribed opioid all day, every
day?
• Or occasional use of cannabis at home, and not impaired at work?
Anecdote from a patient
Case example
30
31. “Legal” substances in the workplace
31
We have a federal law against
cannabis use, however consider
all the pharmaceuticals that can
alter the mind that workers use
every day – consider the effects
on the brain and work
performance
Consider alcohol which is
sometimes actively SERVED in
the workplace!
Consider cigarettes which are
detrimental to health
Amphetamines/stimulants
Opioids
Benzodiazepines
Antidepressants
Antihistamines
Gabapentin/Lyrica
Seizure medication
Beta blockers
32. Summary
• Medicinal Cannabis has the potential to replace several pharmaceuticals that may be
highly toxic and even lethal and that may impair workers
• Medical Cannabis has the potential for analgesia, neuromodulatory, antiepileptic, and
effects for PTSD
• Cannabis is also misused as a drug of abuse and needs to be kept out of young
hands, there is a difference between heavy and light, occasional use.
• The role of medical cannabis is difficult to study due to variability of formulation and
existing laws
• Consider racial inequality in prosecution of drug crimes and the role of gang violence
in illicit cannabis. Before dismissing recreational cannabis, consider both sides.
• Occupational Medicine experts generally recommend banning marijuana in the
workplace as there are so many variables.
• Consider neuropsychiatric testing if there is a concern
• Positive screens should be handled on a case-by-case basis, taking into account the
potential for bias in these decisions. Decisions should be color-blind.
• An attitude of “harm reduction” may be considered